P. Bernard and F. Antonicelli, Bullous pemphigoid: a review of its diagnosis, associations and treatment, Am J Clin Dermatol, vol.18, pp.513-541, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01825913

F. Fichel, C. Barbe, P. Joly, C. Bedane, P. Vabres et al., Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study, JAMA Dermatol, pp.25-33, 2014.

D. Giusti, G. Gatouillat, L. Jan, S. Plée, J. Bernard et al., Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome. Sci Rep, vol.7, p.4833, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01825916

L. Jan, S. Plée, J. Vallerand, D. Dupont, A. Delanez et al., Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid, J Invest Dermatol, vol.134, pp.2908-2925, 2014.

J. Plée, L. Jan, S. Giustiniani, J. Barbe, C. Joly et al., Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome, Sci Rep, vol.5, p.18001, 2015.

M. Riani, L. Jan, S. Plée, J. Durlach, A. et al., Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes, J Allergy Clin Immunol, vol.139, pp.863-72, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01754072

H. Shen, Y. Yang, X. Meng, X. Luo, X. Li et al., NLRP3: a promising therapeutic target for autoimmune diseases, Autoimmun Rev, vol.17, pp.694-702, 2018.

S. Z. Ben-sasson, A. Hogg, J. Hu-li, P. Wingfield, X. Chen et al., IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells, J Exp Med, vol.210, pp.491-502, 2013.

Y. Chung, S. H. Chang, G. J. Martinez, X. O. Yang, R. Nurieva et al., Critical regulation of early Th17 cell differentiation by interleukin-1 signaling, Immunity, vol.30, pp.576-87, 2009.

F. Ghiringhelli, L. Apetoh, A. Tesniere, L. Aymeric, Y. Ma et al., Activation of the NLRP3 inflammasome in dendritic cells induces IL-1? -dependent adaptive immunity against tumors, Nat Med, vol.15, pp.1170-1178, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00419823

N. Koyama, N. Harada, T. Takahashi, S. Mita, H. Okamura et al., Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation, Immunology, vol.63, pp.277-83, 1988.

C. W. Frevert, J. Felgenhauer, M. Wygrecka, M. V. Nastase, and L. Schaefer, Dangerassociated molecular patterns derived from the extracellular matrix provide temporal control of innate immunity, J Histochem Cytochem, vol.66, pp.213-240, 2018.

S. Verraes, W. Hornebeck, M. Polette, L. Borradori, and P. Bernard, Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (Type XVII Collagen) in human bullous pemphigoid, J Invest Dermatol, vol.117, pp.1091-1097, 2001.
URL : https://hal.archives-ouvertes.fr/inserm-00153458

F. Ameglio, D. 'auria, L. Bonifati, C. Ferraro, C. Mastroianni et al., Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity, Br J Dermatol, vol.138, pp.611-615, 1998.

H. Fang, S. Shao, T. Cao, J. Lei, E. Dang et al., Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid, J Dermatol Sci, vol.83, pp.116-139, 2016.

E. Schmidt, A. Mittnacht, H. Schömig, R. Dummer, E. B. Bröcker et al., Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid, J Dermatol Sci, vol.11, pp.142-149, 1996.

P. Tabatabaei-panah, H. Moravvej, Z. Sadaf, H. Babaei, M. Geranmayeh et al., Cytokine Gene Polymorphisms in Bullous Pemphigoid. Front Immunol, vol.10, p.636, 2019.

E. Latz, T. S. Xiao, and A. Stutz, Activation and regulation of the inflammasomes, Nat Rev Immunol, vol.13, pp.397-411, 2013.

M. N. Patel, R. G. Carroll, S. Galván-peña, E. L. Mills, R. Olden et al., Inflammasome priming in sterile inflammatory disease, Trends Mol Med, vol.23, pp.165-80, 2017.

A. Rubartelli, Redox control of NLRP3 inflammasome activation in health and disease, J Leukoc Biol, vol.92, pp.951-959, 2012.

K. Cho, J. W. Suh, K. H. Lee, J. L. Kang, and S. Woo, IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1? by keratinocytes via the ROS-NLRP3-caspase-1 pathway, Int Immunol, vol.24, pp.147-58, 2012.

S. Zhang, N. Yu, R. Zhang, S. Zhang, and J. Wu, Interleukin-17A Induces IL-1? Secretion From RPE Cells Via the NLRP3 Inflammasome, Invest Ophthalmol Vis Sci, vol.57, pp.312-321, 2016.

H. Zhang, R. Fu, C. Guo, Y. Huang, H. Wang et al., Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages, J Transl Med, vol.14, p.156, 2016.

L. Vaillant, P. Bernard, P. Joly, C. Prost, B. Labeille et al., Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group, Arch Dermatol, vol.134, pp.1075-80, 1998.

D. F. Murrell, B. S. Daniel, P. Joly, L. Borradori, M. Amagai et al., Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts, J Am Acad Dermatol, vol.66, pp.479-85, 2012.

S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno et al., Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int J Cancer, vol.26, pp.171-177, 1980.

D. Furman, J. Chang, L. Lartigue, C. R. Bolen, F. Haddad et al., Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states, Nat Med, vol.23, pp.174-84, 2017.

T. Dainichi, A. Kitoh, A. Otsuka, S. Nakajima, T. Nomura et al., The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis, Nat Immunol, vol.19, pp.1286-98, 2018.

H. Sadeghi, A. Lockmann, A. Hund, U. Samavedam, E. Pipi et al., Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules, J Immunol Baltim, vol.194, pp.3656-63, 2015.

D. Giusti, E. Bini, C. Terryn, K. Didier, L. Jan et al., NET formation in bullous pemphigoid patients with relapse is modulated by IL-17 and IL-23 interplay, Front Immunol, vol.10, p.701, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02274404

U. Schönbeck, F. Mach, and P. Libby, Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing, J Immunol Baltim, vol.161, pp.3340-3346, 1998.

C. A. Dinarello, A. Simon, and J. Van-der-meer, Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases, Nat Rev Drug Discov, vol.11, pp.633-52, 2012.